Results 211 to 220 of about 3,364,352 (377)

Evaluation of a New Routine Diagnostic Test for Immunoglobulin E Sensitization to Neuromuscular Blocking Agents [PDF]

open access: bronze, 2010
D. Laroche   +8 more
openalex   +1 more source

Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early‐Onset and Familial Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Leucine‐rich repeat kinase 2 (LRRK2) p.L1795F variant was proposed as a genetic risk factor for Parkinson's disease (PD). However, its prevalence, phenotype, and origin remain unknown. Objective The aim was to evaluate the frequency and phenotype of p.L1795F in early‐onset PD (EOPD) and familial PD compared to healthy controls (HC ...
Miriam Ostrozovicova   +35 more
wiley   +1 more source

Adenosine potentiation of neuromuscular blocking agents in guinea-pigs

open access: bronze, 2000
Keiichi Nitahara   +5 more
openalex   +1 more source

The effects of sevoflurane with propofol and remifentanil on tracheal intubation conditions without neuromuscular blocking agents [PDF]

open access: gold, 2010
Wook Jong Kim   +6 more
openalex   +1 more source

Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review

open access: yesEuropean Journal of Anaesthesiology, 2017
Najat Tajaâte   +4 more
semanticscholar   +1 more source

Proteomic Profiling Informs Mechanisms of Esophageal Adenocarcinoma Inhibition by Cranberry Proanthocyanidins

open access: yesMolecular Nutrition &Food Research, EarlyView.
In this study we utilized proteomic profiling to investigate mechanisms linked to the cancer‐inhibitory effect of cranberry proanthocyanidins (CPACs) on reflux‐induced esophageal adenocarcinoma in a rat model. The results indicate that CPAC inhibits cancer through targeting multiple hallmarks of cancer known to be dysregulated in progression to ...
Yun Zhang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy